Edition:
United Kingdom

Kangmei Pharmaceutical Co Ltd (600518.SS)

600518.SS on Shanghai Stock Exchange

21.01CNY
14 Feb 2018
Change (% chg)

¥0.27 (+1.30%)
Prev Close
¥20.74
Open
¥20.82
Day's High
¥21.10
Day's Low
¥20.62
Volume
9,356,849
Avg. Vol
22,347,666
52-wk High
¥23.90
52-wk Low
¥17.15

Latest Key Developments (Source: Significant Developments)

Kangmei Pharmaceutical unit to acquire 80 pct stake in medical instruments firm for 16 mln yuan
Wednesday, 10 Jan 2018 

Jan 10(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>:Says co's Shanghai-based wholly owned pharmaceutical unit plans to acquire 80 percent stake in a Shandong-based medical instruments firm, at the price of 16 million yuan .  Full Article

Kangmei Pharmaceutical to set up two Chinese herbal medicines related units in Yunfu and Tongren
Wednesday, 10 Jan 2018 

Jan 10(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>:Says it plans to invest 20 million yuan to set up two Chinese herbal medicines related wholly owned units in Yunfu and Tongren.  Full Article

Kangmei Pharmaceutical to acquire 80 pct stake in Huizhou-based pharmaceutical firm for 20.8 mln yuan
Friday, 29 Dec 2017 

Dec 29(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS> ::Says it plans to acquire 80 percent stake in Huizhou-based pharmaceutical firm for 20.8 million yuan .  Full Article

Kangmei Pharmaceutical to invest 50 mln yuan to set up wholly owned medical appliances firm
Friday, 29 Dec 2017 

Dec 29(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS> ::Says its unit will invest 50 million yuan to set up a Beijing-based wholly owned medical appliances firm .  Full Article

Kangmei Pharmaceutical to invest 47.5 mln yuan to set up genetic tech JV in Shenzhen
Friday, 8 Dec 2017 

Dec 8(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>:Says it plans to invest 47.5 million yuan to set up a genetic technology JV with BGI Genomics Co Ltd <<<300676.SZ>>>, with registered capital of 50 million yuan, in Shenzhen .Says the company will hold a 95 percent stake in the JV .  Full Article

Kangmei Pharmaceutical's controlling shareholder issues 2017 second tranche exchangeable bonds worth 3 bln yuan
Sunday, 3 Dec 2017 

Dec 3(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>:Says its controlling shareholder issues 2017 second tranche non-public exchangeable bonds worth 3 billion yuan, with a term of three years .  Full Article

Kangmei Pharmaceutical signs strategic cooperation agreement with local government
Tuesday, 21 Nov 2017 

Nov 21(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>:Says it signs strategic cooperation agreement with local government of Dingxi city, Gansu province.Says two entities will cooperate on medicine related business .  Full Article

Kangmei Pharmaceutical says controlling shareholder issues 2017 1st tranche non-public exchangeable bonds worth 2 bln yuan
Wednesday, 8 Nov 2017 

Nov 8(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>:Says co's controlling shareholder, an industry investment firm, issued 2017 first tranche non-public exchangeable bonds worth 2 billion yuan, with term of 3 years.  Full Article

Kangmei Pharmaceutical to sell 100 pct stake in Weihai-based bioengineering firm for 2.2 mln yuan
Monday, 30 Oct 2017 

Oct 30(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS> ::Says it plans to sell 100 percent stake in a Weihai-based bioengineering firm for 2.2 million yuan .  Full Article

Kangmei Pharmaceutical's 9-month profit up, to invest in three units and acquire a firm
Friday, 27 Oct 2017 

Oct 27 (Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>:Says 9-month net profit up 21.6 percent y/y.Says it plans to invest 160 million yuan ($24.05 million) to set up three units.Says it plans to acquire pharmaceutical firm for up to 140 million yuan.  Full Article

BRIEF-Kangmei Pharmaceutical unit to acquire 80 pct stake in medical instruments firm for 16 mln yuan

* Says co's Shanghai-based wholly owned pharmaceutical unit plans to acquire 80 percent stake in a Shandong-based medical instruments firm, at the price of 16 million yuan